Korawit Juprasertporn: Call for Papers – Thrombosis and Antithrombotic Therapy
Korawit Juprasertporn, Section Managing Editor at MDPI, shared a post on LinkedIn:
“Call for Papers – Journal of Clinical Medicine (JCM) MDPI
Cutting-Edge research on Thrombosis and Antithrombotic Therapy
This Special Issue is led by Dr. Sina Rashedi, dedicated to advancing research on thrombosis and antithrombotic therapy.
This rapidly evolving field that continues to shape modern cardiovascular and vascular medicine.
Thrombotic disorders remain a leading cause of morbidity and mortality worldwide, contributing to conditions such as myocardial infarction, ischemic stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE).
While remarkable progress has been made in anticoagulant and antiplatelet therapies, achieving the optimal balance between thrombosis prevention and bleeding risk remains a major clinical challenge.
We invite original research, comprehensive reviews, clinical studies, and expert perspectives that provide new insights into the prevention, diagnosis, and treatment of thrombotic diseases and improve patient outcomes.
Submission Deadline: 1 June 2027.”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 18:03Manisha Madkaikar: Clinical, Hematological, and Molecular Features of Sickle β-Thalassemia
-
Sep 19, 2026, 17:24Jan Shawqi Goran: Understanding Beta Thalassemia Before Marriage Testing
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community